FDA Import Refusal 799-6241705-2/71/1 — Glaxo India
The FDA refused shipment 799-6241705-2/71/1 from Glaxo India (India) on Mar 14, 2025. The refused product falls under Drugs and Biologics — LOPERAMIDE HYDROCHLORIDE (ANTI-PERISTALTIC, ANTI-DIARRHEAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 14, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62KDA08 LOPERAMIDE HYDROCHLORIDE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
- Charges
- 75